Retroperitoneal Single-Port Robot-Assisted Nephroureterectomy with Bladder Cuff Excision: Initial Experience and Description of the Technique
Journal of Clinical Medicine · 21.09.2023 · 12 (18) · 6091
DOI: 10.3390/jcm12186091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.09.2023. Verfasst von Seokhwan Bang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Fund of Seoul St.Mary’s Hospital, The Catholic University of Korea, Korean government (Ministry of Science and ICT, Ministry of Trade, Industry and Energy, Ministry of Health & Welfare, Republic of Korea, Ministry of Food a….
Abstract (Originalsprache)
Background
With the introduction of the single-port (SP) robot, surgery that was difficult to attempt is becoming possible. Nephroureterectomy (NUx) for upper tract urothelial carcinoma also seems to be able to attempt a retroperitoneal (RP) approach. Purpose: to investigate the feasibility of SP robotic RP NUx with bladder cuff excision. Design, setting, and participants: we sequentially analyzed 20 patients who underwent SP robot NUx from January 2021 to December 2022. Surgical procedure: all patients were diagnosed with upper tract urothelial carcinoma (UTUC) and were operated upon by a single expert using the da Vinci SP platform (Intuitive Surgical, Sunnyvale, CA, USA) with retroperitoneal approach. Results and limitations: A total of 20 patients underwent SP robotic NUx with bladder cuff excision. The mean age of patients was 69.45 ± 8.68 years, and the mean body mass index (BMI) was 25.37 ± 3.00 kg/m2. The mean tumor size was 2.42 ± 1.03 cm on a CT scan, with right-sided tumors in eight patients (40%) and left-sided tumors in 12 patients (60%). The median console time was 106 min and 40 s, and the expected blood loss was 122.50 ± 75.18 mL. Final pathology showed that all of the patients were diagnosed as having urothelial carcinoma; one patient was classified as Ta (5.00%), three patients were classified as T1 (15.00%), seven patients were classified as T2 (35.00%), eight patients were classified as T3 (40.00%), and one patient was classified as T4 (5.00%). None of these 20 patients showed any complications based on the Clavien–Dindo scale.
Conclusions
SP robotic NUx using a retroperitoneal approach provides feasible perioperative and postoperative outcomes for UTUC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Seokhwan Bang, Ji Youl Lee
Förderung
- Research Fund of Seoul St.Mary’s Hospital, The Catholic University of Korea
- Korean government (Ministry of Science and ICT, Ministry of Trade, Industry and Energy, Ministry of Health & Welfare, Republic of Korea, Ministry of Food a…
Zitieren
APA
Bang, S., Cho, H. J., Ha, U. S., Lee, J. Y., & Hong, S. H. (2023). Retroperitoneal Single-Port Robot-Assisted Nephroureterectomy with Bladder Cuff Excision: Initial Experience and Description of the Technique. Journal of Clinical Medicine, 12(18), 6091. https://doi.org/10.3390/jcm12186091
Vancouver
Bang S, Cho HJ, Ha US, Lee JY, Hong SH. Retroperitoneal Single-Port Robot-Assisted Nephroureterectomy with Bladder Cuff Excision: Initial Experience and Description of the Technique. Journal of Clinical Medicine. 2023;12(18):6091. doi:10.3390/jcm12186091
BibTeX
@article{Bang2023,
author = {Bang, Seokhwan and Cho, Hyuk Jin and Ha, U-Syn and Lee, Ji Youl and Hong, Sung-Hoo},
title = {Retroperitoneal Single-Port Robot-Assisted Nephroureterectomy with Bladder Cuff Excision: Initial Experience and Description of the Technique},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {18},
pages = {6091},
doi = {10.3390/jcm12186091}
}
EUVIMED